Jump to content

Nephrocalcin

From Wikipedia, the free encyclopedia
(Redirected from Draft:Nephrocalcin)

Nephrocalcin is an acidic glycoprotein, is produced by renal proximal tubule cells. It inhibits crystal nucleation, growth and aggregation.[1] It is one of the key inhibitors for Nephrolithiasis, kidney stone disease.[2]

There are at least 4 known isoforms of Nephrocalcin: NC-A, NC-B, NC-C, and NC-D.[3] A higher secretion of NC-C and NC-D is found in kidney stone patients, whereas a higher secretion of NC-A and NC-B in non-patients.

References

[edit]
  1. ^ Asplin, J.; DeGanello, S.; Nakagawa, Y. N.; Coe, F. L. (November 1991). "Evidence that nephrocalcin and urine inhibit nucleation of calcium oxalate monohydrate crystals". The American Journal of Physiology. 261 (5 Pt 2): F824–830. doi:10.1152/ajprenal.1991.261.5.F824. ISSN 0002-9513. PMID 1951713.
  2. ^ Negri, A. L.; Spivacow, F. R. (2023-03-25). "Kidney stone matrix proteins: Role in stone formation". World Journal of Nephrology. 12 (2): 21–28. doi:10.5527/wjn.v12.i2.21. PMC 10075018. PMID 37035509.
  3. ^ Nakagawa, Y. (March 1997). "Properties and function of nephrocalcin: mechanism of kidney stone inhibition or promotion". The Keio Journal of Medicine. 46 (1): 1–9. doi:10.2302/kjm.46.1. ISSN 0022-9717. PMID 9095576.